Indications
Pimecrolimus Cream is a second-line treatment for mild to moderate atopic dermatitis. Doctors use it for short-term treatment and for noncontinuous treatment of long-lasting (chronic) disease. It is meant for adults and for children 2 years of age and older who are not immunocompromised. It is given when other topical prescription treatments haven't worked well enough, or when those treatments are not advisable.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Nobody knows exactly how Pimecrolimus works in atopic dermatitis. What has been shown is that it binds to macrophilin-12 (FKBP-12) and blocks calcineurin, a calcium-dependent phosphatase. This stops T cells from being activated.
More specifically, Pimecrolimus blocks the synthesis of several cytokines in human T cells. These are Interleukin-2 and Interferon gamma (Th1-type), and Interleukin-4 and Interleukin-10 (Th2-type). In vitro, Pimecrolimus also stops mast cells from releasing inflammatory cytokines and mediators after they are stimulated by antigen/IgE.
Pregnancy & Breastfeeding
Pimecrolimus is Pregnancy Category C. Nobody knows yet whether the components of the preparation pass into human milk. Pimecrolimus and breastfeeding should not be continued together at the same time.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.